{"disease":{"id":"oligometastatic-lung-tumor","name":"oligometastatic lung tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07441941","title":"Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup","phase":"","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Institut du Cancer de Montpellier - Val d'Aurelle","has_results":false},{"nct_id":"NCT06236516","title":"One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}